Imricor Medical Systems Inc (IMR) - Net Assets
Based on the latest financial reports, Imricor Medical Systems Inc (IMR) has net assets worth AU$23.08 Million AUD (≈ $16.33 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$55.57 Million ≈ $39.32 Million USD) and total liabilities (AU$32.49 Million ≈ $22.99 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check IMR cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$23.08 Million |
| % of Total Assets | 41.54% |
| Annual Growth Rate | N/A |
| 5-Year Change | -125.6% |
| 10-Year Change | N/A |
| Growth Volatility | 172.99 |
Imricor Medical Systems Inc - Net Assets Trend (2016–2024)
This chart illustrates how Imricor Medical Systems Inc's net assets have evolved over time, based on quarterly financial data. Also explore IMR current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for Imricor Medical Systems Inc (2016–2024)
The table below shows the annual net assets of Imricor Medical Systems Inc from 2016 to 2024. For live valuation and market cap data, see IMR stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | AU$-7.38 Million ≈ $-5.22 Million |
+15.72% |
| 2023-12-31 | AU$-8.75 Million ≈ $-6.19 Million |
-216.55% |
| 2022-12-31 | AU$7.51 Million ≈ $5.31 Million |
-66.47% |
| 2021-12-31 | AU$22.40 Million ≈ $15.85 Million |
-22.26% |
| 2020-12-31 | AU$28.82 Million ≈ $20.39 Million |
+309.70% |
| 2019-12-31 | AU$7.03 Million ≈ $4.98 Million |
-47.78% |
| 2018-12-31 | AU$13.47 Million ≈ $9.53 Million |
+356.44% |
| 2017-12-31 | AU$-5.25 Million ≈ $-3.72 Million |
-30.31% |
| 2016-12-31 | AU$-4.03 Million ≈ $-2.85 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Imricor Medical Systems Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 11499930100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$27.02K | % |
| Other Components | AU$134.88 Million | % |
| Total Equity | AU$-7.38 Million | 100.00% |
Imricor Medical Systems Inc Competitors by Market Cap
The table below lists competitors of Imricor Medical Systems Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
EUROKAI GmbH & Co. KGaA
F:EUK3
|
$448.62 Million |
|
Zhongtong Guomai Communication
SHG:603559
|
$448.62 Million |
|
Huang Hsiang Construction Corp
TW:2545
|
$448.64 Million |
|
Iteos Therapeutics Inc
NASDAQ:ITOS
|
$448.68 Million |
|
Ram Ratna Wires Limited
NSE:RAMRAT
|
$448.49 Million |
|
Ganso Co Ltd
SHG:603886
|
$448.48 Million |
|
Hankook Shell Oil
KO:002960
|
$448.42 Million |
|
Bystronic AG
SW:BYS
|
$448.35 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Imricor Medical Systems Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -12,828,267 to -7,377,033, a change of 5,451,234.
- Net loss of 29,692,831 reduced equity.
- Share repurchases of 1,905,897 reduced equity.
- New share issuances of 32,906,291 increased equity.
- Other factors increased equity by 4,143,671.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-29.69 Million | -402.5% |
| Share Repurchases | AU$1.91 Million | -25.84% |
| Share Issuances | AU$32.91 Million | +446.06% |
| Other Changes | AU$4.14 Million | +56.17% |
| Total Change | AU$- | % |
Book Value vs Market Value Analysis
This analysis compares Imricor Medical Systems Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | AU$-0.04 | AU$1.98 | x |
| 2017-12-31 | AU$-0.05 | AU$1.98 | x |
| 2018-12-31 | AU$0.14 | AU$1.98 | x |
| 2019-12-31 | AU$0.07 | AU$1.98 | x |
| 2020-12-31 | AU$0.25 | AU$1.98 | x |
| 2021-12-31 | AU$0.17 | AU$1.98 | x |
| 2022-12-31 | AU$0.05 | AU$1.98 | x |
| 2023-12-31 | AU$-0.08 | AU$1.98 | x |
| 2024-12-31 | AU$-0.03 | AU$1.98 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Imricor Medical Systems Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3094.86%
- • Asset Turnover: 0.04x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-70.58%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | -780.61% | 0.20x | 0.00x | AU$-5.09 Million |
| 2017 | 0.00% | -1186.48% | 0.19x | 0.00x | AU$-6.19 Million |
| 2018 | -54.18% | -543.52% | 0.08x | 1.19x | AU$-8.64 Million |
| 2019 | -210.40% | -2313.28% | 0.06x | 1.50x | AU$-15.50 Million |
| 2020 | -45.38% | -1862.37% | 0.02x | 1.16x | AU$-15.96 Million |
| 2021 | -91.77% | -2952.33% | 0.03x | 1.20x | AU$-22.80 Million |
| 2022 | -233.46% | -2148.77% | 0.06x | 1.82x | AU$-18.29 Million |
| 2023 | 0.00% | -3675.61% | 0.07x | 0.00x | AU$-21.34 Million |
| 2024 | 0.00% | -3094.86% | 0.04x | 0.00x | AU$-28.96 Million |
Industry Comparison
This section compares Imricor Medical Systems Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $41,696,973
- Average return on equity (ROE) among peers: -66.73%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Imricor Medical Systems Inc (IMR) | AU$23.08 Million | 0.00% | 1.41x | $448.50 Million |
| 4DMEDICAL Ltd (4DX) | $3.78 Million | -104.20% | 0.44x | $1.63 Billion |
| Adherium Ltd (ADR) | $2.17 Million | -101.89% | 0.29x | $7.37 Million |
| Aroa Biosurgery Ltd (ARX) | $6.28 Million | -11.51% | 0.04x | $152.13 Million |
| Atomo Diagnostics Ltd (AT1) | $-5.47 Million | 0.00% | 0.00x | $13.76 Million |
| Avita Medical Inc (AVH) | $4.48 Million | -28.68% | 0.02x | $130.53 Million |
| Anteris Technologies Global Corp (AVR) | $1.24 Million | -94.76% | 0.13x | $558.50 Million |
| Control Bionics Ltd (CBL) | $6.09 Million | -15.97% | 0.04x | $16.32 Million |
| Cardiex Ltd (CDX) | $1.33 Million | -328.46% | 1.23x | $13.23 Million |
| Compumedics Ltd (CMP) | $12.20 Million | 3.39% | 0.79x | $39.86 Million |
| Cochlear Ltd (COH) | $384.88 Million | 14.76% | 0.83x | $4.57 Billion |
About Imricor Medical Systems Inc
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include… Read more